Organovo Holdings Inc (ONVO) Stock
ONVO is no longer traded. Organovo Holdings was delisted from the Nasdaq in April 2025.
Prices on this page are historical; the last trade was April 24, 2025 at $1.87.
Organovo Holdings stock price history
ONVO final trading statistics
- Final close
- $1.87
- Final trading day
- Apr 24, 2025
- Market cap at delisting
- $3.37M
- Shares outstanding
- 1.80M
- Final 52-week range
- $0.25 – $4.15
- Avg. volume (final 3 mo.)
- 7,596,390
- All-time high (split-adj.)
- $3060.00 · Nov 2013
- All-time low (split-adj.)
- $1.66 · Apr 2025
- Return since IPO
- -99.5%
- Beta
- 1.13
- Book value / share
- $0.26
- Price / book
- 7.33
Organovo Holdings annual financials
| Fiscal year | Revenue | Net income | EPS |
|---|---|---|---|
| FY2024 | $109.0K | -$14.7M | -$2.01 |
| FY2023 | $370.0K | -$17.3M | -$1.98 |
| FY2022 | $1.50M | -$11.4M | -$1.31 |
| FY2021 | $0.00 | -$16.8M | -$2.47 |
| FY2020 | $2.20M | -$18.7M | -$3.02 |
Last five fiscal years reported before the delisting; fiscal year ending March. EPS is adjusted (non-GAAP) EPS as reported. Source: company filings via EODHD.
About Organovo Holdings Inc
VivoSim Labs, Inc., a biotechnology company, focuses on developing 3D tissues that recapitulate key aspects of human disease. Its 3D human tissue platform includes its proprietary NovoGen Bioprinters, which are automated devices that enable the fabrication of 3D living tissues comprised of mammalian cells; and related technologies for preparing bio-inks and bioprinting multicellular tissues with complex architecture. The company's lead candidate is FXR314, which is phase 2/3clinical trial for indication of inflammatory bowel disease with a clinical focus on ulcerative colitis; and completed phase 1 clinical trial for the indication of liver fibrosis with a clinical focus steatohepatitis. Organovo Holdings, Inc. has research collaborations with Yale School of Medicine, Knight Cancer Institute at Oregon Health & Science University, and the University of Virginia for research of NovoGen Bioprinters. The company was formerly known as Organovo Holdings, Inc. and changed its name to VivoSim Labs, Inc. in April 2025. The company was incorporated in 2007 and is headquartered in San Diego, California.
Organovo Holdings stock FAQ
What happened to Organovo Holdings stock?
Organovo Holdings stock was delisted from the Nasdaq. Its final close was $1.87 on April 24, 2025.
Is ONVO stock still trading?
No. ONVO was delisted from the Nasdaq in April 2025 and no longer trades on a U.S. exchange.
What was the last price of ONVO stock?
ONVO closed at $1.87 on its final trading day, April 24, 2025, for a market value of about $3.37M.
What were Organovo Holdings's revenue and earnings in its last full fiscal year?
Organovo Holdings reported revenue of $109.0K and net income of -$14.7M in fiscal 2024, its last full year as a public company.
When did Organovo Holdings go public?
Organovo Holdings Inc stock began trading on February 14, 2012.